Vext to Announce Financial Results for Q3 2024 on November 21, 2024
Vext Science (CSE: VEXT) (OTCQX: VEXTF), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, has scheduled its Q3 2024 financial results release for November 21, 2024, before market open. The company will host a conference call and webcast on the same day at 8:00 a.m. ET. A replay of the conference call will be available until December 5, 2024, and the webcast will be accessible through Vext's investor website.
Vext Science (CSE: VEXT) (OTCQX: VEXTF), operatore di cannabis con sede negli Stati Uniti e attività verticali in Arizona e Ohio, ha programmato la pubblicazione dei suoi risultati finanziari del terzo trimestre 2024 per il 21 novembre 2024, prima dell'apertura del mercato. L'azienda ospiterà una chiamata e una trasmissione in diretta lo stesso giorno alle 8:00 a.m. ET. Una registrazione della chiamata sarà disponibile fino al 5 dicembre 2024, e la trasmissione in diretta sarà accessibile tramite il sito web per gli investitori di Vext.
Vext Science (CSE: VEXT) (OTCQX: VEXTF), un operador de cannabis con sede en EE. UU. y operaciones verticales en Arizona y Ohio, ha programado la publicación de sus resultados financieros del tercer trimestre de 2024 para el 21 de noviembre de 2024, antes de la apertura del mercado. La compañía llevará a cabo una llamada y transmisión en vivo el mismo día a las 8:00 a.m. ET. Una grabación de la llamada estará disponible hasta el 5 de diciembre de 2024, y la transmisión se podrá acceder a través del sitio web para inversionistas de Vext.
Vext Science (CSE: VEXT) (OTCQX: VEXTF)는 미국에 본사를 두고 아리조나와 오하이오에서 수직 운영을 하는 대마초 운영업체로, 2024년 3분기 재무 결과 발표를 2024년 11월 21일 시장 개장前에 예정하고 있습니다. 회사는 같은 날 오전 8시 ET에 컨퍼런스 콜 및 웹캐스트를 진행할 것입니다. 컨퍼런스 콜의 재생본은 2024년 12월 5일까지 이용 가능하며, 웹캐스트는 Vext 투자자 웹사이트를 통해 접근할 수 있습니다.
Vext Science (CSE: VEXT) (OTCQX: VEXTF), opérateur de cannabis basé aux États-Unis avec des opérations verticales en Arizona et en Ohio, a prévu la publication de ses résultats financiers du troisième trimestre 2024 pour le 21 novembre 2024, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique et un webinaire le même jour à 8h00 ET. Un enregistrement de la conférence téléphonique sera disponible jusqu'au 5 décembre 2024, et le webinaire sera accessible via le site Web des investisseurs de Vext.
Vext Science (CSE: VEXT) (OTCQX: VEXTF), ein in den USA ansässiger Cannabisbetreiber mit vertikalen Aktivitäten in Arizona und Ohio, hat die Veröffentlichung seiner Finanzergebnisse für das dritte Quartal 2024 für den 21. November 2024, vor Markteröffnung, geplant. Das Unternehmen wird am selben Tag um 8:00 Uhr ET eine Telefonkonferenz und einen Webcast abhalten. Eine Aufzeichnung der Telefonkonferenz wird bis zum 5. Dezember 2024 verfügbar sein, und der Webcast wird über die Investorenwebsite von Vext zugänglich sein.
- None.
- None.
Vancouver, British Columbia--(Newsfile Corp. - November 7, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced that it plans to release its financial results for the third quarter ended September 30, 2024, before market open on November 21, 2024.
The Company will host a conference call and webcast on the same day, Thursday, November 21, 2024, at 08:00 a.m. ET.
CONFERENCE CALL DETAILS
Date: November 21, 2024 | Time: 8:00 am E.T.
Participant Dial-in: +1-647-484-8814 or 1-844-763-8274
Replay Dial-in: +1-412-317-0088 or 1-855-669-9658
Conference ID: 10194423
Playback #: 7488060 (Expires on December 5, 2024)
Listen to webcast: https://www.gowebcasting.com/13849
A replay of the conference call and webcast will be available on Vext's investor website following the conclusion of the call. For more details, contact the IR team at investors@vextscience.com.
About Vext Science, Inc.
Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. Vext's expertise spans from cultivation through to retail operations in its key markets. Based out of Arizona, Vext owns and operates state-of-the-art cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company manufactures Vapen™, one of the leading THC concentrates, edibles, and distillate cartridge brands in Arizona. Its selection of award-winning products are created with Vext's in-house, high-quality flower and distributed across Arizona and Ohio, as well as through Vext's partnerships in other states. Vext's leadership team brings a proven track record of building and operating profitable multi-state operations, with the Company having operated profitably since 2016. The Company's primary focus is to continue growing in its core states of Arizona and Ohio, bringing together cutting-edge science, manufacturing, and marketing to provide a reliable and valuable customer experience while generating shareholder value.
Vext Science, Inc. is listed on the Canadian Securities Exchange under the symbol VEXT and trades on the OTCQX market under the symbol VEXTF. Learn more at www.vextscience.com and connect with Vext on Twitter/X and LinkedIn.
For more details on the Vapen brand:
Vapen website: VapenBrands.com
Instagram: @vapen
Facebook: @vapenbrands
Forward-Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Vext's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding the expected filing date of the financial results, future developments and the business and operations of the Vext, all of which are subject to the risk factors contained in Vext's continuous disclosure filed on SEDAR+ at www.sedarplus.ca.
Although Vext has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; being engaged in activities currently considered illegal under U.S. Federal laws; change in laws; reliance on management; requirements for additional financing; competition; hindered market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Vext disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Vext does not assume any liability for disclosure relating to any other company mentioned herein.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
Eric Offenberger
Chief Executive Officer
844-211-3725
For further information:
Jonathan Ross, Vext Investor Relations
jon.ross@loderockadvisors.com
416-244-9851
SOURCE: Vext Science, Inc
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/229081
FAQ
When will Vext Science (VEXTF) release its Q3 2024 earnings?
What time is Vext Science (VEXTF) Q3 2024 earnings call?
How long will Vext Science (VEXTF) Q3 2024 earnings call replay be available?
